The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

被引：0
|
作者：
Kobalava, Z. [1 ]
Villevalde, S. [1 ]
Tyukhmenev, E. [1 ]
Lukina, O. Olga [1 ]
Babaeva, L. [1 ]
Zharikova, E. [1 ]
机构：
[1] Peoples Friendship Univ Russia, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1466
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [1] THE COMBINATION DRUG VALSARTAN/SACUBITRIL (LCZ696) REDUCED PULSE WAVE VELOCITY AND AORTIC SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
    Kobalava, Z.
    Babaeva, L.
    Lukina, O.
    Zharikova, E.
    Tyukhmenev, E.
    Villevalde, S.
    JOURNAL OF HYPERTENSION, 2016, 34 : E181 - E182
  • [2] Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction
    Kobalava, Zhanna
    Kotovskaya, Yulia
    Averkov, Oleg
    Pavlikova, Elena
    Moiseev, Valentine
    Albrecht, Diego
    Chandra, Priya
    Ayalasomayajula, Surya
    Prescott, Margaret F.
    Pal, Parasar
    Langenickel, Thomas H.
    Jordaan, Pierre
    Rajman, Iris
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (04) : 191 - 198
  • [3] The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway
    Gundersen, V.
    Eklund, O.
    Hancock, E.
    Hussain, R.
    Ohna, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 203 - 203
  • [4] Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF
    Bohm, Michael
    Young, Robin
    Jhund, Pardeep S.
    Solomon, Scott D.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, VictorC.
    Swedberg, Karl
    Zile, Michael R.
    Packer, Milton
    McMurray, John J. V.
    EUROPEAN HEART JOURNAL, 2017, 38 (15) : 1132 - 1143
  • [5] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN (FORMERLY LCZ696) IN CHRONIC HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION - AN ANALYSIS FOR SWITZERLAND
    Ademi, Z.
    Hancock, E.
    Trueman, D.
    Pfeil, A.
    Haroun, R.
    Deschaseaux, C.
    Schwenkglenks, M.
    VALUE IN HEALTH, 2016, 19 (07) : A655 - A655
  • [6] LCZ696 vs. enalapril in heart failure patients with reduced ejection fraction
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (06) : 634 - 634
  • [7] Sacubitril/valsartan and low blood pressure in heart failure with reduced ejection fraction
    Bruno, Rosa Maria
    Taddei, Stefano
    EUROPEAN HEART JOURNAL, 2017, 38 (15) : 1144 - 1146
  • [8] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [9] Early improvement of symptoms using LCZ696 in a patient with systolic heart failure and a reduced ejection fraction: a case report
    Kohlmeier, Johannes
    Bramlage, Peter
    PERFUSION-UK, 2016, 31 (08): : 699 - 702
  • [10] A COST-EFFECTIVENESS ANALYSIS IN THE US OF LCZ696 (SACUBITRIL/VALSARTAN) VERSUS RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITION FOR HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION
    Gaziano, Thomas A.
    Fonarow, Gregg
    Claggett, Brian
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    McMurray, John
    Chan, Wing
    Turner, Stuart
    Deschaseaux, Celine
    Solomon, Scott
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1302 - 1302
12345